Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Vertex Pharmaceuticals Incorporated    VRTX

Delayed Quote. Delayed  - 04/29 10:00:00 pm
84.34 USD   -2.78%
04/27 VERTEX PHARMACE : reports 1Q loss
04/27 VERTEX PHARMACE : Reports First Quarter 2016 Financial Results
04/19 VERTEX PHARMACE : Enterome signs IBD therapy agreement with Vertex
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Vertex Pharmaceuticals Inc
Discovers and develops novel, small molecule pharmaceuticals

Vertex Pharmaceuticals, Inc. engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases in specialty markets.

It focuses on development and commercializing therapies for the treatment of cystic fibrosis; infectious diseases, including viral infections, such as influenza, and bacterial infections; autoimmune diseases, such as rheumatoid arthritis; cancer, inflammatory bowel disease; and neurological disorders, including pain, Huntington's disease and multiple sclerosis.

The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.

Number of employees : 1 950 persons.
Sales per Businesses
20142015Delta
USD (in Million)%USD (in Million)%
Pharmaceuticals580.42100%1,032100% +77.86%
Sales per Regions
20142015Delta
USD (in Million)%USD (in Million)%
United States361.0762.2%763.3273.9% +111.4%
Europe197.6134%219.6021.3% +11.13%
Other21.733.7%49.424.8% +127.45%
Managers
NameAgeSinceTitle
Jeff Leiden602009Chairman, President & Chief Executive Officer
Simon Bedson, MBA-2011SVP & GM-International Commercial Operations
Ian F. Smith492001CFO, EVP & Principal Financial Officer
Jeffrey A. Chodakewitz, MD602014Chief Medical Officer & Executive Vice President
David Matthew Altshuler MD, PhD512012Chief Scientific Officer & EVP-Global Research
Joshua S. Boger, PhD641989Director
Bruce I. Sachs, MBA561998Lead Independent Director
Elaine S. Ullian681997Lead Independent Director
Margaret G. McGlynn, MBA552011Independent Director
Terrence C. Kearney, MBA612011Independent Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 247,287,000 245,268,303 99.2% 0 0.0% 99.2%
Shareholders
NameEquities%
T. Rowe Price Associates, Inc. 25,345,121 10.3%
Capital Research & Management Co. (World Investors) 20,737,911 8.42%
Wellington Management Co. LLP 14,863,986 6.03%
The Vanguard Group, Inc. 14,503,469 5.89%
Fidelity Management & Research Co. 14,263,917 5.79%
BlackRock Fund Advisors 11,687,267 4.74%
SSgA Funds Management, Inc. 9,801,580 3.98%
JPMorgan Investment Management, Inc. 9,499,547 3.86%
Columbia Management Investment Advisers LLC 8,604,161 3.49%
ClearBridge Investments LLC 7,712,258 3.13%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Bio Therapeutic Drugs
Advertisement
Sector Biotechnology & Medical Research
Growth (Revenue) Profitability
GILEAD SCIENCES, ..
AMGEN, INC.
CELGENE CORPORATI..
REGENERON PHARMAC..
VERTEX PHARMACEUT..
ACTELION LTD
MEDIVATION INC
GENMAB A/S
JUNO THERAPEUTICS..
TONGHUA DONGBAO P..
HUALAN BIOLOGICAL..
NEUROCRINE BIOSCI..
INTERCEPT PHARMAC..
PEPTIDREAM INC
CHINA BIOLOGIC PR..
BEIJING SL PHARMA..
ULTRAGENYX PHARMA..
KITE PHARMA INC
ZHONGYUAN UNION C..
ANHUI ANKE BIOTEC..
Sector Biotechnology & Medical Research
Vertex Pharmaceuticals Inc : Connections
SpiderCloud Wireless, Inc.
The Alliance for Business Leadership
Institute of Medicine
The Boston Private Industry Council, Inc.
The American Institute of Certified Public Accountants
Massachusetts Workforce Board Association
Institute of Chartered Accountants in England & Wales
Jibo, Inc.
The Financial Executives Institute
Abington Friends School
Ravinia Festival Association
American Civil Liberties Union Foundation, Inc.
Infectious Diseases Society of America
Nantero, Inc.
The American Society for Clinical Pharmacology & Therapeutics
DataGravity, Inc.
Vertex Pharmaceuticals
iControl Networks, Inc.
New England Aquarium Corp.
Macp Organization
Massachusetts Institute of Technology
Clarus Ventures LLC
The Broad Institute, Inc.
Museum of Science
Whitehead Institute for Biomedical Research
WGBH Educational Foundation
American Society for Clinical Investigation
Massachusetts Life Sciences Center
Association of American Physicians
Accelerated Cure Project for Multiple Sclerosis
Alkeus Pharmaceuticals, Inc.
SimpliVity Corp.
New England Healthcare Institute
GreatCall, Inc.
American Academy of Arts & Sciences
OneCloud Software, Inc.
Massachusetts Mutual Life Insurance Co.
Charles River Ventures, Inc.
Celebrity Series of Boston, Inc.
Biolex Therapeutics, Inc.
The Hastings Center
The Brigham & Women's Hospital, Inc.
Massachusetts Life Sciences Collaborative
Orphan Technologies Ltd.
Biotechnology Industry Organization
Wesleyan University
Harvard Medical School
Company contact information
50 avenue Northern
US-MA 02110 Boston, Massachusetts
États-Unis (les)

Phone : +1 617 444 6100
Fax : +1 617 444 6680
Internet : http://www.vpharm.com
Markets and indexes
- NASDAQ All Markets
- Nasdaq Global Select Market
- Nasdaq 100 / SP500
Stock Exchange Codes
- ISIN Code :  US92532F1003
- Bloomberg Code :  VRTX:US
- Reuters Code :  VRTX.O
- Datastream Code :  
© 2016 People , Fundamentals and Ownership    © 2016 Cofisem